Thalia Therapeutics' Chief Executive Dr David Solomon tells focusIR about what the Company's current portfolio contains and ...Read More
U.S. Gold Corp. has completed its CK Gold Feasibility Study and secured key project permits but management believes the story ...Read More
Lightning Minerals CEO Troy Brice says new soil sampling at the Mount Turner Gold Project in Queensland has reinforced the ...Read More
Arc Minerals CEO Remy Welschinger talked with Proactive at the latest One2One Investor Forum about the company's copper ...Read More
Lightning Minerals CEO Troy Brice says soil sampling at Mount Turner's Drummer Fault has reinforced six drill targets and ...Read More
Critical Resources Ltd has confirmed high-grade tungsten at the Granite Creek target within its Croesus Project in New Zealand.Read More
Stijn Schmitz welcomes Doug Casey to the show. Doug Casey is a Bestselling Author, Speculator, Founder of Casey Research, ...Read More
Investors are using leveraged ETFs all wrong and losing money on thematic ETFs because they don't know how to use these ...Read More
Subscribe for our FREE newsletter - #1 place for gold & silver news & commentary: http://libertyandfinance.com. CANADIANS ...Read More
Interview with Elaine Ellingham, President & CEO of Omai Gold Mines Corp. Our previous interview: ...Read More
The same mindset that builds your initial wealth can easily become the psychological prison that keeps you from enjoying it.Read More
Scorpio Gold CEO and director Zayn Kalyan provides an update on the exploration progress at the 100%-owned Manhattan ...Read More
Critical Resources Ltd has delivered standout first-pass tungsten results from Granite Creek, part of its Croesus Project on New ...Read More
The S&P 500 closed outside its weekly expected move and the Nasdaq just took a brutal hit with semiconductors down 7.31% on ...Read More
Serval Resources CEO Robin Birchall presented at the Proactive One2One Investor Forum, discussing the company's recently ...Read More
Thalia Therapeutics' Chief Executive Dr David Solomon explains what the next steps are for miRisten as well as when the top line ...Read More
Learn More about Rego Consulting: ...Read More
Thalia Therapeutics' Chief Executive Dr David Solomon details what miRisten is and how it treats Leukemia at this stage of its ...Read More
Light Science Technologies (AIM:LST) CEO Simon Deacon joined Proactive's Stephen Gunnion to discuss strong early ...Read More
Learn More about Rego Consulting: ...Read More